330 related articles for article (PubMed ID: 12496437)
1. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
[TBL] [Abstract][Full Text] [Related]
2. Increased C5a receptor expression in sepsis.
Riedemann NC; Guo RF; Neff TA; Laudes IJ; Keller KA; Sarma VJ; Markiewski MM; Mastellos D; Strey CW; Pierson CL; Lambris JD; Zetoune FS; Ward PA
J Clin Invest; 2002 Jul; 110(1):101-8. PubMed ID: 12093893
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a functional role of the second C5a receptor C5L2.
Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA
FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of C5a receptor in mouse microvascular endothelial cells.
Laudes IJ; Chu JC; Huber-Lang M; Guo RF; Riedemann NC; Sarma JV; Mahdi F; Murphy HS; Speyer C; Lu KT; Lambris JD; Zetoune FS; Ward PA
J Immunol; 2002 Nov; 169(10):5962-70. PubMed ID: 12421982
[TBL] [Abstract][Full Text] [Related]
5. C5a receptor and thymocyte apoptosis in sepsis.
Riedemann NC; Guo RF; Laudes IJ; Keller K; Sarma VJ; Padgaonkar V; Zetoune FS; Ward PA
FASEB J; 2002 Jun; 16(8):887-8. PubMed ID: 12039868
[TBL] [Abstract][Full Text] [Related]
6. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
7. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg).
Werfel T; Oppermann M; Butterfield JH; Begemann G; Elsner J; Götze O; Zwirner J
Scand J Immunol; 1996 Jul; 44(1):30-6. PubMed ID: 8693289
[TBL] [Abstract][Full Text] [Related]
8. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells.
Wetsel RA
Immunol Lett; 1995 Jan; 44(2-3):183-7. PubMed ID: 7797249
[TBL] [Abstract][Full Text] [Related]
9. Protection of innate immunity by C5aR antagonist in septic mice.
Huber-Lang MS; Riedeman NC; Sarma JV; Younkin EM; McGuire SR; Laudes IJ; Lu KT; Guo RF; Neff TA; Padgaonkar VA; Lambris JD; Spruce L; Mastellos D; Zetoune FS; Ward PA
FASEB J; 2002 Oct; 16(12):1567-74. PubMed ID: 12374779
[TBL] [Abstract][Full Text] [Related]
10. Induction of functional anaphylatoxin C5a receptors on hepatocytes by in vivo treatment of rats with IL-6.
Schieferdecker HL; Schlaf G; Koleva M; Götze O; Jungermann K
J Immunol; 2000 May; 164(10):5453-8. PubMed ID: 10799912
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with interleukin-6 small interfering RNA can improve the survival rate of polymicrobial cecal ligation and puncture mice by down regulating interleukin-6 production.
Mostafa Anower AK; Shim JA; Choi B; Sohn S
Eur J Pharmacol; 2012 Aug; 688(1-3):76-83. PubMed ID: 22634167
[TBL] [Abstract][Full Text] [Related]
12. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans.
Huber-Lang M; Sarma JV; Rittirsch D; Schreiber H; Weiss M; Flierl M; Younkin E; Schneider M; Suger-Wiedeck H; Gebhard F; McClintock SD; Neff T; Zetoune F; Bruckner U; Guo RF; Monk PN; Ward PA
J Immunol; 2005 Jan; 174(2):1104-10. PubMed ID: 15634936
[TBL] [Abstract][Full Text] [Related]
13. Anti-complement strategies in experimental sepsis.
Ward PA; Riedemann NC; Guo RF; Huber-Lang M; Sarma JV; Zetoune FS
Scand J Infect Dis; 2003; 35(9):601-3. PubMed ID: 14620141
[TBL] [Abstract][Full Text] [Related]
14. [Complement 5a regulates the function of dendritic cells to induce pathogenic polarization of regulatory T cell/helper T cell 17 in sepsis].
Qi A; Wang T; Chai Y; Zhang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jan; 33(1):17-22. PubMed ID: 33565394
[TBL] [Abstract][Full Text] [Related]
15. Role of C5a-C5aR interaction in sepsis.
Guo RF; Riedemann NC; Ward PA
Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
[TBL] [Abstract][Full Text] [Related]
16. Expression of the anaphylatoxin C5a receptor in non-myeloid cells.
Zwirner J; Fayyazi A; Götze O
Mol Immunol; 1999; 36(13-14):877-84. PubMed ID: 10698342
[TBL] [Abstract][Full Text] [Related]
17. C5a, a therapeutic target in sepsis.
Guo RF; Ward PA
Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):57-65. PubMed ID: 18221134
[TBL] [Abstract][Full Text] [Related]
18. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
[TBL] [Abstract][Full Text] [Related]
19. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.
Haviland DL; McCoy RL; Whitehead WT; Akama H; Molmenti EP; Brown A; Haviland JC; Parks WC; Perlmutter DH; Wetsel RA
J Immunol; 1995 Feb; 154(4):1861-9. PubMed ID: 7836770
[TBL] [Abstract][Full Text] [Related]
20. Expression and induction of anaphylatoxin C5a receptors in the rat liver.
Schlaf G; Schmitz M; Rothermel E; Jungermann K; Schieferdecker HL; Götze O
Histol Histopathol; 2003 Jan; 18(1):299-308. PubMed ID: 12507307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
